We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00000859
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : October 1, 2013
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)